GE HealthCare Technologies Inc. (GEHC)
Summary
GEHC Stock Up on $500M Strategic Care Alliance With Catholic Health
GE HealthCare's shares rise about 4% after unveiling a $500M, 10-year alliance to deploy 1,300 technologies across Catholic Health.
Do Options Traders Know Something About GE HealthCare Stock We Don't?
Investors need to pay close attention to GEHC stock based on the movements in the options market lately.
GE HealthCare & Mayo Clinic Unite to Advance Cancer Theranostics
GEHC and Mayo Clinic collaboration aims to advance adaptive cancer theranostics using imaging, biomarkers and clinical data from the MI-BET study.
GE HealthCare Technologies Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| TJD Thomas John Drogan PR Inc.IPAL SECURITIES Inc. | 5,436 | $420,539.06 | $343,745.46 | -$76,793.6 | -18.26% |
| DI David Izzi Brown, LISLE/CUMMINGS Inc. | 546 | $40,826.66 | $34,526.31 | -$6,300.35 | -15.43% |
| TMB Timothy M. Bidwell Hazlett, BURT & WATSON Inc. | 142 | $11,639.2 | $8,979.37 | -$2,659.83 | -22.85% |
| LC Lisa Candera CIGNA INVESTMENTS Inc. /NEW | 4,290 | $356,212.23 | $271,278.15 | -$84,934.08 | -23.84% |
| CE Curtis Ellergodt Rothschild Investment LLC | 2,496 | $192,546.9 | $157,834.56 | -$34,712.34 | -18.03% |
GE HealthCare Technologies Inc. Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Jason Bednar Piper Sandler | 143.35 | $11,028.96 | $9,016.65 | -$2,012.31 | -18.25% |
GE HealthCare Technologies Inc. (GEHC) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has GE HealthCare Technologies Inc. ever had a stock split?
GE HealthCare Technologies Inc. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Peter J. Arduini CEO | NASDAQ (NGS) Exchange | 36266G107 CUSIP |
| US Country | 53,000 Employees | 24 Jul 2026 Last Dividend | - Last Split | 4 Jan 2023 IPO Date |
Overview
GE HealthCare Technologies Inc. is a globally recognized company deeply engaged in the healthcare sector, providing a wide range of products, services, and digital solutions aimed at improving patient care. With operations spread across the United States, Canada, and other international markets, the company commits itself to the development, manufacture, and marketing of innovative medical technologies. The organizational structure of GE HealthCare Technologies Inc. is divided into four primary segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics, each dedicated to addressing specific medical needs and advancing the field of medical diagnostics and patient care. Having evolved from GE Healthcare Holding LLC in December 2022, the company is now based in Chicago, Illinois, and continues to leverage its broad portfolio to facilitate the diagnosis, treatment, and monitoring of patients worldwide.
Products and Services
- Imaging
This segment provides a comprehensive range of imaging technologies such as molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. These advanced imaging solutions play a crucial role in diagnosing and managing various health conditions, enhancing the efficiency and effectiveness of medical treatments.
- Ultrasound
GE HealthCare Technologies Inc. offers a wide array of ultrasound devices and solutions designed for screening, diagnosis, treatment, and monitoring of diseases in numerous clinical areas. This includes radiology, primary care, women's health, cardiovascular, along with point of care and handheld ultrasound devices, and products for surgical visualization and guidance. Ultrasound technology facilitates non-invasive diagnostics and therapeutic procedures, making it an essential tool in modern healthcare.
- Patient Care Solutions
The company's offerings under this segment encompass a variety of medical devices, consumables, services, and digital solutions aimed at improving patient outcomes. The portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, and maternal infant care products, alongside a range of consumables and services. These solutions are integral to providing comprehensive care in various medical settings, from emergency rooms to intensive care units and beyond.
- Pharmaceutical Diagnostics
Specializing in diagnostic agents for radiology and nuclear medicine, this segment supplies essential products for CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound imaging. The products include contrast media pharmaceuticals that improve the visibility of tissues during diagnostic scans and molecular imaging agents or radiopharmaceuticals labeled with radioisotopes for detailed imaging studies. These diagnostic agents are pivotal in detecting and monitoring a wide range of diseases, aiding clinicians in formulating effective treatment plans.
